SCHEMBL3530273

SCHEMBL3530273

COC(=O)CNC(=O)c1cccc(/C=C/C(=O)c2c(N3CCCCC3)cc(C)oc2=O)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.42
LMNA P02545 5/20 0.42
MAPK1 P28482 4/20 0.42
ALDH1A1 P00352 3/20 0.42
L3MBTL1 Q9Y468 3/20 0.42
TDP1 Q9NUW8 2/20 0.42
NPSR1 Q6W5P4 3/20 0.41
POLB P06746 3/20 0.41
RECQL P46063 2/20 0.41
USP2 O75604 2/20 0.41
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
KDM4E B2RXH2 2/20 0.40
TP53 P04637 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
RAB9A P51151 3/20 0.37
NPC1 O15118 2/20 0.37
PKM P14618 1/20 0.37
HTT P42858 2/20 0.37
GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3530276 1.00 MAPT (0.42) MAPTLMNAMAPK1ALDH1A1L3MBTL1
SCHEMBL3525659 0.93 MAPT (0.44) MAPTALDH1A1L3MBTL1TDP1NPSR1
SCHEMBL3525657 0.93 MAPT (0.44) MAPTALDH1A1L3MBTL1TDP1NPSR1
SCHEMBL3530441 0.84 MAPT (0.57) MAPTALDH1A1NPSR1POLBRECQL
SCHEMBL3530444 0.84 MAPT (0.57) MAPTALDH1A1NPSR1POLBRECQL
SCHEMBL3525664 0.76 RAB9A (0.42) MAPTLMNAMAPK1ALDH1A1L3MBTL1
SCHEMBL3525665 0.76 RAB9A (0.42) MAPTLMNAMAPK1ALDH1A1L3MBTL1
SCHEMBL2281269 0.73 P4HB (0.41) MAPTMAPK1NPSR1POLBRECQL
SCHEMBL2281265 0.73 P4HB (0.41) MAPTMAPK1NPSR1POLBRECQL
SCHEMBL2278780 0.72 MAPK1 (0.42) MAPTMAPK1ALDH1A1NPSR1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7691883-B2 Cinnamoyl compound and use of the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-04-06 US disclosed
US-20070265228-A1 Cinnamoyl compound and use of the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-11-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070265228-A1 Cinnamoyl compound and use of the same NPC1, CES2, CYP51A1 MAPT 2195/4885LMNA 1109/4885MAPK1 4089/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.